[Esophageal carcinoma after the endoscopic sclerotherapy of varices].
We report the case of a 52-years-old smoking male, diagnosed of liver cirrhosis, who developed a squamous cell carcinoma of the esophagus 36 months after undergoing endoscopic injection sclerotherapy for bleeding esophageal varices. Nine courses with 3% polidocanol were performed along 10 months. It was injected intra and paravariceal at a total dose of 117 ml. The relationship between endoscopic injection sclerotherapy and developing squamous cell carcinoma of the esophagus is discussed.
Macías Rodríguez
M A
MA
Servicio de Aparato Digestivo, Hospital Universitario Puerta del Mar, Cádiz.
Soria de la Cruz
M J
MJ
Iglesias Arrabal
M
M
Martín Herrera
L
L
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000209:etiology*; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000209:etiology*; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000628:therapy; D004945:Esophagoscopy; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000627:therapeutic use; D015911:Sclerotherapy / Q000009:adverse effects*; D013997:Time Factors
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols
Carcinoma esofágico tras escleroterapia endoscópica de varices.